glp 1 market size 2024 GLP-1 Agonists Weight Loss Drugs Report, 2025-2030 Market Overview: GLP-1 Agonists and

Its defining characteristic in the research literature is a "clean" hormonal profile: robust, dose-dependent GH release without the meaningful elevations in cortisol, prolactin, ACTH, or appetite seen with earlier-generation secretagogues

People taking semaglutide for weight loss fall into every single one of those categories

Doses used clinically generally start modestly and can be adjusted upward based on the patient, with the intravenous route favored precisely because it sidesteps the oral-absorption question

Some people prefer to take their dose a day early so that any initial fatigue or digestive issues happen before their trip begins, rather than during it